Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Clinical trial NCT01679197 · COMPLETED
Trial details
- NCT number
- NCT01679197
- Sponsor
- University of Michigan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-08
- Primary completion
- 2016-07-13
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.